Evidence map›Paper›PMID 28752210›Full record

ReviewEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2017

Helicobacter pylori infection and atherosclerosis: is there a causal relationship?

Z Xu, J Li, H Wang, G Xu

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05024864 (HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction), which is not on this map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05024864 naactive not recruitingnot on this mapstarted 2021, after this paper: background citation

HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in Patients With Acute Myocardial Infarction (HELP-MI SWEDEHEART)

TypeinterventionalSponsorKarolinska InstitutetRan2021 to 2030Enrolled20,000ConditionsMyocardial Infarction, Helicobacter Pylori Infection, GastroIntestinal Bleeding, Cardiovascular DiseasesArmsUrea breath test (UBT)
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Current issues in molecular biology · 2026
    Review
  2. Interpretable machine learning analysis for relationships betweenFrontiers in cellular and infection microbiology · 2026
    Article
  3. Review
  4. The Detection ofPathogens (Basel, Switzerland) · 2024
    Article
  5. Article
  6. Role ofBiomedicines · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Life (Basel, Switzerland) · 2022
    Article
  11. Review
  12. Association ofFrontiers in cardiovascular medicine · 2021
    Article
  13. The Effects ofFrontiers in immunology · 2021
    Review
  14. Journal of the American Heart Association · 2020
    Article
  15. Exosome-Transmitted miR-25 Induced byFrontiers in cellular and infection microbiology · 2019
    Article
  16. Diagnostic methods for Helicobacter pylori infection: ideals, options, and limitations.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Z XuDepartment of Neurology, Jinling Hospital, Southern Medical University, 305 East Zhongshan Road, Nanjing, Jiangsu, 210002, China.
J LiDepartment of Neurology, Jiangning Hospital Affiliated to Nanjing Medical University, Nanjing, Jiangsu, 211100, China.
H WangDepartment of Neurology, Jinling Hospital, Second Military Medical University, Nanjing, 21002, China.
G XuDepartment of Neurology, Jinling Hospital, Southern Medical University, 305 East Zhongshan Road, Nanjing, Jiangsu, 210002, China. gelinxu@nju.edu.cn.
Nanjing Medical University · CNNanjing General Hospital of Nanjing Military Command · CNSecond Military Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

For many years, the coexistence of Helicobacter pylori (H. pylori) infection and atherosclerotic diseases in a disproportional number of patients has inspired the presumption that a causal relationship exists between the conditions. This presumption was evidenced by the simultaneously declining epidemics of duodenal ulcer and coronary artery diseases in the United States in the past 40 years, and was further evidenced by the detection of H. pylori and their DNA in atherosclerotic plaques. Suggested mechanisms underlying this possible causality include intensified inflammatory stress, dyslipidemia, abnormal glucose metabolism, arterial stiffness, increased blood pressure and malnutrition. However, a causal relationship was disproved by results from other studies, which indicated that common risk factors shared by H. pylori infection and atherosclerosis, such as aging, cigarette smoking, disadvantageous socioeconomic status and high salt intake, may predestine their coexistence. Understanding the nature of the relationship between H. pylori infection and atherosclerosis is of vital importance, because a causality may indicate a possible strategy for preventing and treating atherosclerosis by eradicating H. pylori infection in selected individuals. This review assessed current evidence for and against a causal relationship between H. pylori infection and atherosclerosis.

Indexed as

Helicobacter pyloriAnimalsAtherosclerosisHelicobacter InfectionsHumansInflammationRisk AssessmentRisk Factors

Identifiers

PMID28752210
OpenAlexW2740095826

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.